X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-03-15 | LFST | Lifestance Health Group, Inc. | Burdick Kenneth A | CEO | S - Sale | $6.28 | -214,605 | 2,934,372 | -7% | -$1,347,719 | ||||||
D | 2024-03-18 | WGS | Genedx Holdings Corp. | Stueland Katherine | CEO | S - Sale+OE | $10.59 | -8,559 | 66,698 | -11% | -$90,661 | |||||
D | 2024-03-18 | WGS | Genedx Holdings Corp. | Saad Kareem | Chief Transformation Officer | S - Sale+OE | $10.59 | -2,008 | 29,517 | -6% | -$21,269 | |||||
D | 2024-03-18 | WGS | Genedx Holdings Corp. | Feeley Kevin | CFO | S - Sale+OE | $10.59 | -3,253 | 28,927 | -10% | -$34,455 | |||||
2024-03-14 | LFST | Lifestance Health Group, Inc. | Mullins Kevin Michael | Chief Development Officer | S - Sale | $6.33 | -44,540 | 4,745,352 | -1% | -$281,938 | ||||||
2024-03-14 | LFST | Lifestance Health Group, Inc. | Pardo Ryan | See Remarks | S - Sale | $6.33 | -39,384 | 3,369,297 | -1% | -$249,301 | ||||||
2024-03-15 | DCGO | Docgo Inc. | Katz Steven | Dir | P - Purchase | $3.64 | +13,500 | 69,534 | +24% | +$49,140 | ||||||
2024-03-14 | DCGO | Docgo Inc. | Rosenberg Norman | CFO, Treasurer | P - Purchase | $3.61 | +10,000 | 407,419 | +3% | +$36,100 | ||||||
2024-03-13 | LFST | Lifestance Health Group, Inc. | Qureshi Danish J. | See Remarks | S - Sale | $6.32 | -153,943 | 10,814,035 | -1% | -$972,920 | ||||||
2024-03-13 | USPH | U S Physical Therapy Inc /nv | Hendrickson Carey P | CFO | S - Sale | $107.28 | -1,800 | 21,186 | -8% | -$193,103 | ||||||
2024-03-13 | USPH | U S Physical Therapy Inc /nv | Binstein Richard | EVP Gen'l Counsel, Secretary | S - Sale | $106.55 | -2,000 | 15,006 | -12% | -$213,100 | ||||||
2024-03-13 | USPH | U S Physical Therapy Inc /nv | Trier Clayton | Dir | S - Sale | $107.00 | -400 | 7,000 | -5% | -$42,800 | ||||||
2024-03-14 | DCGO | Docgo Inc. | Burdiek Michael J | Dir | P - Purchase | $3.61 | +10,000 | 571,595 | +2% | +$36,100 | ||||||
2024-03-13 | USPH | U S Physical Therapy Inc /nv | Ham Nancy | Dir | S - Sale | $107.89 | -500 | 860 | -37% | -$53,945 | ||||||
2024-03-12 | LFST | Lifestance Health Group, Inc. | Pantaleoni Pablo | Chief Digital Officer | S - Sale | $6.76 | -43,304 | 1,310,043 | -3% | -$292,735 | ||||||
2024-03-12 | WGS | Genedx Holdings Corp. | Feeley Kevin | CFO | S - Sale | $9.21 | -931 | 24,983 | -4% | -$8,574 | ||||||
2024-03-12 | WGS | Genedx Holdings Corp. | Stueland Katherine | CEO | S - Sale | $9.21 | -2,618 | 56,507 | -4% | -$24,111 | ||||||
2024-03-12 | WGS | Genedx Holdings Corp. | Saad Kareem | Chief Transformation Officer | S - Sale | $9.21 | -897 | 26,411 | -3% | -$8,261 | ||||||
2024-03-11 | LFST | Lifestance Health Group, Inc. | Cipollone Paula | See Remarks | S - Sale | $6.93 | -13,996 | 293,562 | -5% | -$96,992 | ||||||
2024-03-11 | LFST | Lifestance Health Group, Inc. | Varanakis Ann | Chief People Officer | S - Sale | $6.93 | -15,434 | 268,276 | -5% | -$106,958 | ||||||
2024-03-11 | LFST | Lifestance Health Group, Inc. | Bourdon David | CFO | S - Sale | $6.93 | -58,826 | 433,856 | -12% | -$407,664 | ||||||
M | 2024-03-08 | PRVA | Privia Health Group, Inc. | Sullivan William M | Dir | S - Sale | $23.03 | -7,515 | 5,467,810 | 0% | -$173,066 | |||||
M | 2024-03-04 | WGS | Genedx Holdings Corp. | Casdin Capital, LLC | Dir, 10% | P - Purchase | $8.74 | +40,900 | 3,472,697 | +1% | +$357,652 | |||||
2024-03-04 | USPH | U S Physical Therapy Inc /nv | Reeve Graham D. | COO | S - Sale | $104.39 | -2,629 | 25,162 | -9% | -$274,441 | ||||||
2024-03-04 | USPH | U S Physical Therapy Inc /nv | Williams Eric Joseph | Co-Chief Operations Officer | S - Sale | $104.96 | -1,500 | 19,314 | -7% | -$157,440 | ||||||
2024-03-04 | USPH | U S Physical Therapy Inc /nv | Kuntz Edward L | Dir | S - Sale | $104.26 | -2,500 | 5,780 | -30% | -$260,650 | ||||||
D | 2024-03-04 | WGS | Genedx Holdings Corp. | Feeley Kevin | CFO | S - Sale+OE | $8.57 | -301 | 23,452 | -1% | -$2,580 | |||||
2024-03-01 | LFST | Lifestance Health Group, Inc. | Mullins Kevin Michael | Chief Development Officer | S - Sale | $8.02 | -115,136 | 4,575,480 | -2% | -$923,391 | ||||||
D | 2024-02-23 | PNTG | Pennant Group, Inc. | Guerisoli Brent | Pres | S - Sale+OE | $17.11 | -1,385 | 80,142 | -2% | -$23,697 | |||||
M | 2024-01-24 | PRVA | Privia Health Group, Inc. | Sullivan William M | Dir | S - Sale | $23.08 | -21,951 | 5,475,325 | 0% | -$506,732 | |||||
D | 2024-01-22 | WGS | Genedx Holdings Corp. | Saad Kareem | Chief Transformation Officer | S - Sale+OE | $3.24 | -193 | 24,467 | -1% | -$625 | |||||
2024-01-03 | WGS | Genedx Holdings Corp. | Saad Kareem | Chief Transformation Officer | S - Sale | $2.58 | -105 | 24,114 | 0% | -$271 | ||||||
2023-12-28 | PRVA | Privia Health Group, Inc. | Sullivan William M | Dir | S - Sale | $23.97 | -12,000 | 5,497,276 | 0% | -$287,640 | ||||||
D | 2023-12-18 | WGS | Genedx Holdings Corp. | Stueland Katherine | CEO | S - Sale+OE | $2.16 | -11,734 | 52,578 | -18% | -$25,338 | |||||
D | 2023-12-18 | WGS | Genedx Holdings Corp. | Saad Kareem | Chief Transformation Officer | S - Sale+OE | $2.16 | -1,700 | 23,946 | -7% | -$3,671 | |||||
D | 2023-12-18 | WGS | Genedx Holdings Corp. | Feeley Kevin | CFO | S - Sale+OE | $2.16 | -2,948 | 23,035 | -11% | -$6,366 | |||||
M | 2023-12-13 | PRVA | Privia Health Group, Inc. | Sullivan William M | Dir | S - Sale | $23.54 | -24,000 | 5,509,276 | 0% | -$564,960 | |||||
2023-12-13 | USPH | U S Physical Therapy Inc /nv | Trier Clayton | Dir | S - Sale | $92.26 | -1,170 | 7,400 | -14% | -$107,944 | ||||||
D | 2023-12-11 | WGS | Genedx Holdings Corp. | Stueland Katherine | CEO | S - Sale+OE | $1.61 | -3,673 | 45,562 | -7% | -$5,915 | |||||
D | 2023-12-11 | WGS | Genedx Holdings Corp. | Saad Kareem | Chief Transformation Officer | S - Sale+OE | $1.61 | -850 | 20,532 | -4% | -$1,369 | |||||
D | 2023-12-11 | WGS | Genedx Holdings Corp. | Feeley Kevin | CFO | S - Sale+OE | $1.61 | -908 | 18,786 | -5% | -$1,462 | |||||
D | 2023-12-04 | WGS | Genedx Holdings Corp. | Feeley Kevin | CFO | S - Sale+OE | $1.77 | -270 | 17,232 | -2% | -$478 | |||||
2023-12-01 | LFST | Lifestance Health Group, Inc. | Mullins Kevin Michael | Chief Development Officer | S - Sale | $6.54 | -113,334 | 4,690,616 | -2% | -$741,204 | ||||||
2023-11-28 | DCGO | Docgo Inc. | Sugrue Stephen | Chief Compliance Officer | S - Sale | $5.75 | -2,859 | 32,257 | -8% | -$16,439 | ||||||
2023-11-21 | UPH | Uphealth, Inc. | Katz Avi S | Dir | S - Sale | $0.40 | -280 | 480,482 | 0% | -$112 | ||||||
M | 2023-11-16 | WGS | Genedx Holdings Corp. | Ryan Jason | Exec COB | P - Purchase | $1.41 | +114,742 | 120,576 | >999% | +$161,368 | |||||
D | 2023-11-15 | WGS | Genedx Holdings Corp. | Meister Keith A. | Dir, 10% | S - Sale+OE | $1.29 | -883,742 | 3,012,443 | -23% | -$1,140,027 | |||||
2023-11-15 | USPH | U S Physical Therapy Inc /nv | Reeve Graham D. | COO | S - Sale | $87.39 | -1,500 | 19,691 | -7% | -$131,085 | ||||||
2023-11-10 | USPH | U S Physical Therapy Inc /nv | Gilmartin Kathleen A | Dir | P - Purchase | $82.34 | +1,000 | 15,480 | +7% | +$82,340 | ||||||
2023-11-08 | WGS | Genedx Holdings Corp. | Pfenniger Richard C Jr | Dir | P - Purchase | $1.49 | +10,000 | 20,918 | +92% | +$14,889 | ||||||
M | 2023-11-06 | LFST | Lifestance Health Group, Inc. | Mullins Kevin Michael | Chief Development Officer | S - Sale | $6.12 | -32,356 | 4,803,950 | -1% | -$198,019 | |||||
2023-11-03 | LFST | Lifestance Health Group, Inc. | Mullins Kevin Michael | Chief Development Officer | S - Sale | $6.13 | -80,977 | 4,836,306 | -2% | -$496,389 | ||||||
D | 2023-10-20 | WGS | Genedx Holdings Corp. | Saad Kareem | Chief Transformation Officer | S - Sale+OE | $3.44 | -164 | 18,541 | -1% | -$564 | |||||
2023-10-17 | WGS | Genedx Holdings Corp. | Ryan Jason | Exec COB | S - Sale | $3.19 | -42 | 5,834 | -1% | -$134 | ||||||
2023-10-16 | DCGO | Docgo Inc. | Bienstock Lee | CEO | S - Sale | $5.89 | -1,667 | 299,037 | -1% | -$9,819 | ||||||
D | 2023-10-02 | DCGO | Docgo Inc. | Tendler Ely D | GC, Secretary | S - Sale+OE | $5.29 | -10,000 | 23,088 | -30% | -$52,900 | |||||
A | 2023-09-11 | PIII | P3 Health Partners Inc. | Chicago Pacific Founders Ugp Iii, LLC | 10% | P - Purchase | $2.52 | +90,000 | 49,845,442 | 0% | +$227,142 | |||||
AM | 2023-09-11 | PIII | P3 Health Partners Inc. | Chicago Pacific Founders Ugp Iii, LLC | 10% | P - Purchase | $2.54 | +270,000 | 49,755,442 | +1% | +$684,963 | |||||
AM | 2023-09-05 | PIII | P3 Health Partners Inc. | Chicago Pacific Founders Ugp Iii, LLC | 10% | P - Purchase | $2.07 | +270,000 | 49,575,442 | +1% | +$558,639 | |||||
A | 2023-09-01 | PIII | P3 Health Partners Inc. | Chicago Pacific Founders Ugp Iii, LLC | 10% | P - Purchase | $2.07 | +90,000 | 98,520,884 | 0% | +$186,570 | |||||
2023-10-02 | LFST | Lifestance Health Group, Inc. | Mullins Kevin Michael | Chief Development Officer | S - Sale | $6.61 | -113,333 | 4,917,283 | -2% | -$749,131 | ||||||
D | 2023-10-03 | WGS | Genedx Holdings Corp. | Saad Kareem | Chief Transformation Officer | S - Sale+OE | $3.56 | -85 | 18,159 | 0% | -$303 | |||||
2023-09-25 | DTOC | American Oncology Network, Inc. | Saba Capital Management, L.P. | 10% | S - Sale | $10.50 | -205,512 | 0 | -100% | -$2,157,876 | ||||||
D | 2023-09-18 | WGS | Genedx Holdings Corp. | Stueland Katherine | CEO | S - Sale+OE | $4.16 | -10,752 | 42,689 | -20% | -$44,749 | |||||
D | 2023-09-18 | WGS | Genedx Holdings Corp. | Saad Kareem | Chief Transformation Officer | S - Sale+OE | $4.16 | -1,580 | 17,971 | -8% | -$6,575 | |||||
D | 2023-09-18 | WGS | Genedx Holdings Corp. | Feeley Kevin | CFO | S - Sale+OE | $4.16 | -2,742 | 16,785 | -14% | -$11,409 | |||||
2023-09-15 | DCGO | Docgo Inc. | Bienstock Lee | CEO | S - Sale | $6.32 | -1,667 | 300,704 | -1% | -$10,535 | ||||||
D | 2023-09-15 | DCGO | Docgo Inc. | Tendler Ely D | GC, Secretary | S - Sale+OE | $5.91 | -10,000 | 23,088 | -30% | -$59,100 | |||||
2023-09-15 | PRVA | Privia Health Group, Inc. | Sullivan William M | Dir | S - Sale | $25.03 | -18,153 | 5,533,276 | 0% | -$454,432 | ||||||
2023-09-11 | PIII | P3 Health Partners Inc. | Chicago Pacific Founders Ugp Iii, LLC | 10% | P - Purchase | $2.52 | +90,000 | 50,115,442 | 0% | +$227,142 | ||||||
M | 2023-09-11 | PIII | P3 Health Partners Inc. | Chicago Pacific Founders Ugp Iii, LLC | 10% | P - Purchase | $2.54 | +270,000 | 50,025,442 | +1% | +$684,963 | |||||
D | 2023-09-11 | WGS | Genedx Holdings Corp. | Stueland Katherine | CEO | S - Sale+OE | $4.62 | -2,675 | 34,691 | -7% | -$12,369 | |||||
D | 2023-09-11 | WGS | Genedx Holdings Corp. | Saad Kareem | Chief Transformation Officer | S - Sale+OE | $4.62 | -846 | 14,437 | -6% | -$3,912 | |||||
D | 2023-09-11 | WGS | Genedx Holdings Corp. | Feeley Kevin | CFO | S - Sale+OE | $4.62 | -904 | 12,330 | -7% | -$4,180 | |||||
M | 2023-09-05 | PIII | P3 Health Partners Inc. | Chicago Pacific Founders Ugp Iii, LLC | 10% | P - Purchase | $2.07 | +270,000 | 49,755,442 | +1% | +$558,639 | |||||
D | 2023-09-05 | PRVA | Privia Health Group, Inc. | Bartrum Thomas | EVP, GC | S - Sale+OE | $25.77 | -15,000 | 106,114 | -12% | -$386,550 | |||||
2023-09-01 | DCGO | Docgo Inc. | Capone Anthony | CEO | S - Sale | $9.00 | -2,000 | 404,275 | 0% | -$18,000 | ||||||
D | 2023-09-05 | WGS | Genedx Holdings Corp. | Feeley Kevin | CFO | S - Sale+OE | $4.38 | -269 | 10,772 | -2% | -$1,178 | |||||
2023-09-01 | PRVA | Privia Health Group, Inc. | Sullivan William M | Dir | S - Sale | $26.46 | -18,153 | 5,551,429 | 0% | -$480,328 | ||||||
M | 2023-08-31 | LFST | Lifestance Health Group, Inc. | Gouk Warren | Chief Administrative Officer | S - Sale | $8.25 | -50,024 | 6,700,304 | -1% | -$412,698 | |||||
M | 2023-08-31 | PIII | P3 Health Partners Inc. | Chicago Pacific Founders Ugp Iii, LLC | 10% | P - Purchase | $2.09 | +180,000 | 49,485,442 | 0% | +$375,570 | |||||
M | 2023-08-28 | PIII | P3 Health Partners Inc. | Chicago Pacific Founders Ugp Iii, LLC | 10% | P - Purchase | $1.64 | +270,000 | 49,305,442 | +1% | +$443,142 | |||||
M | 2023-08-24 | PIII | P3 Health Partners Inc. | Chicago Pacific Founders Ugp Iii, LLC | 10% | P - Purchase | $1.47 | +180,000 | 49,035,442 | 0% | +$264,393 | |||||
2023-08-24 | LFST | Lifestance Health Group, Inc. | Varanakis Ann | Chief People Officer | S - Sale | $7.60 | -5,661 | 168,441 | -3% | -$43,024 | ||||||
D | 2023-08-22 | DCGO | Docgo Inc. | Tendler Ely D | GC, Secretary | S - Sale+OE | $8.75 | -10,000 | 23,088 | -30% | -$87,500 | |||||
2023-08-18 | PRVA | Privia Health Group, Inc. | Sullivan William M | Dir | S - Sale | $25.06 | -18,153 | 5,569,582 | 0% | -$454,914 | ||||||
2023-08-17 | WGS | Genedx Holdings Corp. | Pfenniger Richard C Jr | Dir | P - Purchase | $5.10 | +5,000 | 10,918 | +84% | +$25,523 | ||||||
2023-08-16 | DCGO | Docgo Inc. | Bienstock Lee | Pres, COO | S - Sale | $10.19 | -1,667 | 302,371 | -1% | -$16,987 | ||||||
2023-08-16 | DCGO | Docgo Inc. | Capone Anthony | CEO | S - Sale | $10.01 | -15,000 | 406,275 | -4% | -$150,150 | ||||||
2023-08-15 | USPH | U S Physical Therapy Inc /nv | Ham Nancy | Dir | S - Sale | $105.81 | -240 | 1,360 | -15% | -$25,394 | ||||||
2023-08-15 | USPH | U S Physical Therapy Inc /nv | Binstein Richard | EVP Gen'l Counsel, Secretary | S - Sale | $106.60 | -1,000 | 8,906 | -10% | -$106,600 | ||||||
M | 2023-08-14 | DCGO | Docgo Inc. | Oberholzer Adriaan Stephanus | See Remarks | S - Sale | $10.26 | -129,029 | 1,114,384 | -10% | -$1,323,870 | |||||
M | 2023-08-11 | USPH | U S Physical Therapy Inc /nv | Kuntz Edward L | Dir | S - Sale | $108.78 | -2,000 | 8,280 | -19% | -$217,550 | |||||
2023-08-11 | USPH | U S Physical Therapy Inc /nv | Reeve Graham D. | COO | S - Sale | $109.99 | -4,114 | 21,191 | -16% | -$452,499 | ||||||
2023-08-04 | PRVA | Privia Health Group, Inc. | Sullivan William M | Dir | S - Sale | $27.10 | -18,153 | 5,587,735 | 0% | -$491,935 | ||||||
D | 2023-08-03 | PRVA | Privia Health Group, Inc. | Bartrum Thomas | EVP, GC | S - Sale+OE | $26.51 | -15,000 | 106,114 | -12% | -$397,689 | |||||
D | 2023-07-31 | PRVA | Privia Health Group, Inc. | Mehrotra Parth | CEO | S - Sale+OE | $28.03 | -31,744 | 153,974 | -17% | -$889,784 | |||||
2023-07-27 | BTTX | Better Therapeutics, Inc. | Perry David P | Exec COB, 10% | P - Purchase | $0.73 | +1,233,045 | 17,082,779 | +8% | +$900,000 | ||||||
2023-07-27 | BTTX | Better Therapeutics, Inc. | Berman Mark A. | Chief Medical Officer | P - Purchase | $0.73 | +54,802 | 388,191 | +16% | +$40,000 | ||||||
2023-07-27 | BTTX | Better Therapeutics, Inc. | Armanino Andrew J. | Dir | P - Purchase | $0.73 | +274,010 | 741,702 | +59% | +$200,000 |
A | Amended filing |
D | Derivative transaction in filing (usually option exercise) |
E | Error detected in filing |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |